pression of an antisense to Nox1 or treatment with an ERK1/2 inhibitor. Conclusions: Following vascular injury, the increased expression of Nox1 in SMCs within the neointima initiates redox-dependent phosphorylation of ERK1/2 and subsequent MMP-9 activation.
Introduction
In response to acute vascular injury, intimal hyperplasia occurs due to the migration of a subset of medial smooth muscle cells (SMCs) to the intima, where they proliferate and assume a noncontractile or synthetic phenotype [1] . Previous studies demonstrate that the SMCs in the neointimal layer are morphologically distinct from 'spindle-shaped' SMCs in the surrounding medial layer [2] . Instead, these epithelioid-shaped cells have different biological properties, including faster proliferation and expression of fewer muscle-specific markers than the spindle-shaped cells [3] [4] [5] [6] .
Vascular reactive oxygen species (ROS) levels are increased following balloon angioplasty, and systemic antioxidant therapy inhibits neointima formation [7] [8] [9] . Several studies implicate NADPH oxidase as the primary source of ROS following injury [7, 8, 10] , and inhibition of NADPH oxidase reduces ROS levels and neointimal hyperplasia [11] . Redox-dependent activation of SMCs by NADPH oxidase promotes migration, proliferation, and extracellular matrix degradation [12, 13] . We hypothesized that in response to acute injury, increased expression and activation of NADPH oxidase by neointimal SMCs promotes intracellular signaling and activates matrix metalloproteinases.
Methods
Detailed protocols are described in online supplementary materials (www.karger.com/doi/10.1159/000332958).
Intimal and Medial SMC Culture
Two weeks after balloon injury by Fogarty 2-Fr arterial embolectomy catheters [14] , rat aortas were harvested and placed in Dulbecco's modified Eagle's medium (DMEM). Four-millimeter segments were obtained for superoxide detection as described below. The remaining aorta was cleaned of freely adhering tissue and cut longitudinally and the endothelium gently removed by scraping. Next, the aorta was incubated in DMEM with 400 U/ml collagenase type 4 at 37 ° C for 20 min, and then neointimal cells were scraped and cultured separately. The remaining medial SMCs were cut into 1-mm sections and incubated in high-glucose DMEM containing 100 U/ml penicillin, 100 g/ml streptomycin, 2 m M L -glutamine, 10 m M HEPES, 1 ! basal medium Eagle vitamins, 1 ! minimum essential media nonessential amino acids, 20% fetal bovine serum (FBS) at 37 ° C for 24 h. Next, sections were incubated with DMEM with 400 U/ml collagenase type 4 and 1.5 U/ml elastase at 37 ° C for 40 min; sections were triturated to accelerate dissociation. Neointimal and medial SMCs were plated on 0.1% gelatin-coated dishes and maintained in DMEM supplemented with 10% FBS, 2 mmol/l L -glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin at 37 ° C in a 5% CO 2 -humidified incubator. Cells were confirmed to be ␣ -actin-positive by immunostaining at passage 3-4. Experiments were performed using SMCs at 70-90% confluence from passages 5-11. When indicated, cells were serum-deprived by changing the media to DMEM containing 0.1% FBS for 24 h. For individual experiments, the passage number was identical for medial and neointimal-derived SMCs.
Superoxide Detection
Aortic segments (4 mm) were rinsed in cold PBS and flashfrozen in OCT as previously described [15] . Sections (30 m) were incubated for 30 min in dihydroethidium (DHE, 10 -5 M ), and examined by fluorescent confocal microscopy (excitation at 488 nm and detection using a 585-nm long-pass filter). Where indicated, sections were pretreated with tiron or diphenylene iodonium (DPI, 10 -4 M ) prior to the addition of DHE. Intracellular superoxide was measured in cultured SMCs after incubation in DHE (10 -5 M , 30 min), and fluorescence intensity was measured by flow cytometry as described [16] . Where indicated, cells were pretreated with DPI (10 -5 M ) or polyethylene-glycolated superoxide dismutase (PEG-SOD, 250 units/ml) prior to DHE staining. NADPHdependent superoxide was measured in membrane-enriched SMC fractions [16] . Briefly, sonicated SMCs were centrifuged (250 g, 10 min). The supernatant was centrifuged (70,000 g , 1 h, 4 ° C), then 20 g of soluble protein was added to PBS containing lucigenin (5 ! 10 -6 M ) and NADPH (10 -4 M ) and placed in an FB12 luminometer. After a 2-min dark adaptation period, measurement of emitted light was obtained every 30 s and averaged over a 5-min period.
Cell Growth
SMCs were serum-deprived in 0.1% FBS for 48-72 h and then incubated in 0.1% serum with 3 H-leucine in the presence or absence of tiron (10 -4 M ) for an additional 24 h. 3 H-leucine incorporation was quantitated using a liquid scintillation counter, and cell growth was quantitated relative to untreated medial SMCs in 0% serum.
Western Blotting
SMCs were lysed and equal amounts of lysates were analyzed by Western blotting with antibodies against ␣ -actin, smooth muscle myosin heavy chain (MHC), mitochondrial (MnSOD) and intracellular (CuZnSOD) isoforms of SOD, catalase, phospho-ERK1/2, and ERK1/2.
Immunohistochemical Probing of p47 phox and p22 phox
Snap-frozen aortae were sectioned (8 m thick) and probed with p47 phox and p22 phox antibodies.
Matrix Metalloproteinase-9 Induction
Gelatinase activity in conditioned media was assayed by gel zymography and normalized to cell number as described [17, 18] .
Adenoviral-Mediated Gene Transfer
Cells were transduced with adenoviruses containing either shRNAs to Nox1 (Ad-shNox1) or GFP (Ad-shGFP) as a control [19] .
Nox1 and Nox4 mRNA Expression
Expression of Nox1 and Nox4 was assessed by quantitative RT-PCR (qRT-PCR) in SMCs and normalized to 18S rRNA.
Statistical Analysis
Results are expressed as mean 8 SEM. Statistical comparisons were performed by Student's two-tailed t test or one-way analysis of variance (ANOVA) with post-hoc analysis with Tukey's multiple comparison posttests. A p value of ! 0.05 was considered significant.
Results
We first characterized the localization of ROS production within the aorta 2 weeks after balloon injury. Injured aorta formed a well-defined neointima with greater DHE fluorescence as compared to the adjacent medial layer, indicating increased ROS levels in the neointima ( fig. 1 a, b) . The fluorescent signal was inhibited by both tiron and DPI treatment, which suggests a flavoenzyme-dependent mechanism of ROS generation, such as NADPH oxidase ( fig. 1 c, d ). Further supporting this observation, the expression of the NADPH oxidase subunits p47 phox and p22 phox was increased in the neointima of the injured artery as compared to the adjacent medial layer and to the noninjured vessels ( fig. 1 e-h ). The majority of cells in the neointima stained positive for ␣ -actin, indicating SMC origin (data not shown). These observations are consistent with previous findings [8] and suggest that, following balloon injury, neointimal SMCs have increased NADPH oxidase expression and activity.
To further examine the role of NADPH oxidase-derived superoxide in the neointima, SMCs were isolated from both the neointimal and medial layers of the injured aorta and studied in culture. Consistent with previous studies [3] [4] [5] [6] , these two distinct sources within the vascular wall provided SMCs with different morphologies, i.e. the neointimal cells exhibited an 'epithelioid' shape that differed from the 'spindle' shape morphology of the medial SMCs ( fig. 2 a) . Neointimal SMCs expressed similar ␣ -actin and no smooth muscle myosin heavy chain (MHC) as compared to medial SMCs ( fig. 2 b) . Similar to our findings in situ, intracellular ROS levels were greater in neointimal SMCs and inhibited by SOD ( fig. 2 c) . This was not due to a reduction in neointimal SMC antioxidant capacity since cytosolic SOD and catalase activity were greater in neointimal SMC (CuZnSOD: 0.86 8 0.07 and catalase: 0.68 8 0.18 medial/neointimal SMC ratio, MnSOD: 1.38 8 0.09; n = 3). The increased ROS levels were also inhibited by DPI ( fig. 2 c) , consistent with NADPH-derived superoxide ( fig. 2 c) . NADPH oxidase activity was greater in membrane-enriched fractions prepared from neointimal SMCs as compared to medial SMCs ( fig. 2 d) . Neointimal SMCs also displayed elevated cell growth in response to 0.1% serum as compared to medial SMCs, and this response was prevented with tiron ( fig. 2 e) .
The observations of cell growth in the absence of a mitogen and increased NADPH oxidase activity led us to hypothesize that neointimal cells have increased expression of Nox1, a catalytic subunit of NADPH oxidase. This subunit has been shown to induce mitogen-independent cell growth [20] . Expression of Nox1 was higher in neointimal-derived SMCs as compared to medial SMCs ( fig. 3 a) . In contrast, expression of Nox4, the other major catalytic NADPH oxidase subunit found in SMCs [13] , was similar between these two vascular SMC subtypes ( fig. 3 b) . We and others have reported that Nox1 expression is associated with ERK activity in SMCs and other cell types [18, [21] [22] [23] [24] . Under quiescent conditions, neointimal but not medial SMCs demonstrated constitutive ERK1/2 phosphorylation, which was inhibited by treatment with tiron and DPI ( fig. 3 c, d ). These data show that, under unstimulated conditions, neointimal cells have increased Nox1 expression and associated redox-dependent activation of ERK.
Degradation of the extracellular matrix by matrix metalloproteinase-9 (MMP-9) contributes to the development of neointima following carotid injury [25] . We pre- viously found that activation of MMP-9 involves ROS and ERK signaling [17] . Conditioned media collected from quiescent intimal SMCs had greater MMP-9 activity than media from medial SMCs ( fig. 4 a) . This increase in MMP-9 secretion was prevented by pretreatment with the ERK1/2 inhibitor PD98059 ( fig. 4 a) or with an shRNA against Nox1 [19] ( fig. 4 b) . In addition, IL-1 ␤ stimulation of neointimal SMCs increased MMP-9 activity to a greater extent than in medial SMCs, an effect that was inhibited by pretreatment with PD98059 ( fig. 4 a) . Similarly, expression of an shRNA to Nox1 prevented the effect of IL-1 ␤ on MMP-9 induction ( fig. 4 b) . These data indicate that the increased MMP-9 activity in quiescent and activated neointimal cells is dependent on Nox1 and ERK activation.
Discussion
Phenotypically distinct subsets of SMCs are activated and contribute to neointimal hyperplasia, yet the molecular characteristics that define the neointimal and medial SMCs are not fully understood. Herein, we demonstrate increased NADPH oxidase expression and activity in the neointimal layer in aortae after balloon injury. Furthermore, SMCs cultured from the neointima differ in morphology and growth as compared to medial SMCs. The neointimal SMCs have increased MMP-9 activity, which results in part from a greater Nox1 expression and ERK activation in these cells. Our results provide a molecular basis for the phenotypic changes observed following vascular injury and implicate Nox1 as an important mediator of neointimal SMC activation.
Our findings of increased ROS in the neointima of the injured vessel are consistent with the pathologic role of ROS since antioxidants prevent intimal formation [26] . The NADPH oxidases have been identified as the primary source of ROS in blood vessels [13] . Expression of the Nox1 NADPH oxidase in the intima is increased early after wire injury, whereas expression of Nox4 remains at normal levels until late in the development of the neointima [8] . Furthermore, mice deficient in Nox1 have less neointimal hyperplasia in the femoral artery after wire injury as compared to wild-type mice [27] , further supporting a direct role for Nox1 in SMC activation. We confirmed the increased expression and activity of NADPH oxidase in the neointima in vivo, validating a role for Nox1-derived ROS in restenosis. We extended these findings by showing increased Nox1 expression and ROS levels in cultured SMCs derived from the neointima following aortic injury. Therefore, the neointimal phenotypic characteristics are preserved in vitro . The formation of the neointima following injury is complex and requires activation of cellular processes involving multiple cell types. Within the medial layer, these processes include matrix degradation by metalloproteinases, thereby allowing migration of SMCs to the subendothelial space and proliferation to form the neointima. With our findings, Nox1 is now implicated in each step of this process. Herein, we show that MMP-9 activity in the neointimal-derived SMCs is increased compared to medial SMCs, and this effect is dependent on the expression of Nox1. Furthermore, migration to basic fibroblast growth factor and to platelet-derived growth factor is impaired in Nox1-deficient SMCs [27, 28] . Finally, expression of Nox1 is sufficient to induce mitogenic activity [20] , and Nox1 null SMCs have decreased rates of growth [27] . In accordance with these observations, we found that neointimal cells had increased serum-independent growth that was prevented by antioxidant. Taken together, these data identify Nox1 as a central mediator in the development of neointimal hyperplasia.
There are several potential mechanisms by which Nox1-derived ROS activate SMCs [29] . Modification of redox-sensitive residues leads to activation of kinases and/or inactivation of phosphatases. These Nox1-dependent changes in turn modulate migration through cytoskeletal remodeling, activation of adaptor proteins, and regulation of adhesion molecules. Nox1 also controls cell growth via activation of cell cycle proteins and transcription factors. Recently, it has been shown that Nox1-derived ROS activate ERK1/2 with a subsequent increase in Nox1 expression [24] . Similarly, we found that neointimal-derived SMCs have increased ERK1/2 activation associated with elevated Nox1 expression. Our data suggest that ERK1/2 phosphorylation in neointimal cells is activated by NADPH oxidase-generated ROS.
Redox-dependent activation of ERK results in induction of MMP-9 in SMCs [17] . We extend these observations by showing that, in neointimal SMCs, ERK is responsible for the increased MMP-9 activity. Furthermore, IL-1 ␤ activation of MMP-9 is Nox1-dependent. MMP-9 activity is an important determinant of vascular disease, contributing to plaque development and instability in atherosclerosis [30, 31] .
One of the interesting observations from this study is the autonomous increase in ROS levels and ERK and MMP-9 activation in neointimal SMCs. The epithelioid neointimal-derived SMCs are known to have an increased proliferative rate as compared to spindle-shaped medial cells [5, 32] . The origin of these different morphologies appears to already exist as subpopulations of SMCs within the medial layer. For example, SMCs in the subendothelial region of larger arteries demonstrate constitutive ERK activity and serum-independent growth unlike SMCs from the middle media [33] . It is not known whether there are differences in Nox1 expression in these distinct subtypes of SMCs within the media. Although many of these phenotypic effects have been attributed to Nox1, differentiation of SMCs is regulated by Nox4 and not Nox1 [34] . The complex interaction between these two SMC-derived NADPH oxidase subunits requires further investigation.
In summary, these findings highlight the role of Nox1 in mediating the SMC response to injury. The therapeutic targeting of Nox1 or its redox-dependent signaling may reduce arterial remodeling associated with vascular disease.
